secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001104659-25-116476
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte terminates $80M at-the-market offering agreement with Jefferies
------------------------------------------------------------------------

- Agreement allowed sale of up to $80M in common stock via Jefferies as agent.
- Termination notice delivered November 21, 2025; effective 10 days later.
- Company is not subject to any termination penalties.
- No new financing or replacement agreement announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925116476/0001104659-25-116476-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925116476/tm2532300d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-116476

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer